Table 2. Effect of naltrexone on other measures of the rGT for the Optimal (n = 15) and Suboptimal (n = 9) groups.
Dose X Group ANOVAs revealed no significant interactions or main effects. Data presented are mean ± SEM. *Indicated a main effect of Group (p<0.05).
| VARIABLE | GROUP | DOSES (mg/kg) | |||
|---|---|---|---|---|---|
| Vehicle | 1 | 3 | 10 | ||
| Trials | Optimal* | 89.55 ± 6.11 | 93.96 ± 8.62 | 97.88 ± 7.85 | 90.1 ± 7.43 |
| Suboptimal | 64.89 ± 3.07 | 66.34 ± 4.24 | 72.13 ± 5.80 | 71.9 ± 8.99 | |
| Omissions | Optimal | 0.97 ± 0.35 | 0.81 ± 0.39 | 1.89 ± 1.70 | 1.02 ± 0.60 |
| Suboptimal | 2.16 ± 1.14 | 2.12 ± 1.47 | 2.98 ± 1.62 | 2.22 ± 1.28 | |
| Premature Responding | Optimal | 12.92 ± 1.91 | 10.52 ± 1.52 | 8.46 ± 1.58 | 10.28 ± 1.68 |
| Suboptimal | 13.17 ± 3.42 | 15.87 ± 4.08 | 12.20 ± 3.17 | 19.01 ± 3.97 | |
| Reward Perseverative | Optimal | .020 ± .01 | .021 ± .01 | .012 ± .01 | .011 ± .003 |
| Suboptimal | .014 ± .01 | .032 ± .02 | .014 ± .01 | ||
| .010 ± .004 | |||||
| Punishment Perseverative | Optimal | .051 ± .01 | .051 ± .01 | .048 ± .01 | .058 ± .01 |
| Suboptimal | .032 ± .01 | .044 ± .01 | .039 ± .01 | .042 ± .01 | |
| Choice Latency | Optimal | 1.38 ± .35 | 1.39 ± .19 | 1.27 ± .14 | 1.37 ± .20 |
| Suboptimal | 0.93 ± .28 | 1.21 ± .21 | 1.28 ± .20 | 1.14 ± .22 | |
| Collect Latency | Optimal | 1.76 ± .11 | 1.80 ± .16 | 1.64 ± .10 | 1.73 ± .13 |
| Suboptimal | 1.64 ± .21 | 1.37 ± .09 | 1.41 ± .08 | 1.94 ± .65 | |